63 - Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Patients with Refractory Aggressive Non-Hodgkin Lymphoma (NHL): Long-Term Follow-up of the Pivotal Zuma-1 Trial
- Resource Type
- Abstract
- Authors
- Neelapu, Sattva S.; Locke, Frederick L.; Bartlett, Nancy L.; Lekakis, Lazaros J.; Miklos, David; Jacobsen, Eric; Braunschweig, Ira; Oluwole, Olalekan; Siddiqi, Tanya; Lin, Yi; Timmerman, John; Reagan, Patrick; Bot, Adrian; Rossi, John; Navale, Lynn; Jiang, Yizhou; Aycock, Jeff; Elias, Meg; Wiezorek, Jeff; Go, William Y.
- Source
- In Biology of Blood and Marrow Transplantation March 2018 24(3) Supplement:S74-S75
- Subject
- Language
- ISSN
- 1083-8791